Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 7Phase 1 4Phase NA 2Phase 4 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Recruiting 4Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 5NETWORK 1INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 2Head & Neck 2Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Nasopharyngeal Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Spinocerebellar Degenerations 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Melanoma 1Esophageal Neoplasms 1

Interventions

Carboplatin 129pembrolizumab 124Cisplatin 114Paclitaxel 102Gemcitabine 85Specimen Handling 80Magnetic Resonance Spectroscopy 80Docetaxel 70Dexamethasone 59Cyclophosphamide 59Pemetrexed 55Bevacizumab 54durvalumab 53Doxorubicin 52Radiotherapy 49Capecitabine 49Radiation 47Oxaliplatin 47Fluorouracil 47Rituximab 42Leucovorin 42Vincristine 41Lenalidomide 40Etoposide 38Letrozole 36atezolizumab 35Nivolumab 35Prednisone 31Bortezomib 31130-nm albumin-bound paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Immune Checkpoint Inhibitors × 90 days × Clear all
NCT07590024 2026-06-04

RAIRI-NPC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Recruiting
651 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05941741 2026-05-11

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Sun Yat-sen University

Phase 3 Recruiting
380 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05522660 2026-04-27

USZ-STRIKE

ETOP IBCSG Partners Foundation

Phase 3 Recruiting
180 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07551479 2026-04-24

TORCH-STAR

Fudan University

Phase 3 Not yet recruiting
612 enrolled

Spinocerebellar Degenerations

NCT07541755 2026-04-21

PD1-VEN-CAG

Fujian Medical University Union Hospital

Phase 3 Active not recruiting
40 enrolled
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06964568 2026-04-17

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

Fudan University

Phase 3 Recruiting
452 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02973789 2026-03-18

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

NovoCure Ltd.

Phase 3 Completed
291 enrolled 22 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡